TY - JOUR
T1 - Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment
AU - Yamagata, Bun
AU - Yamanaka, Kaori
AU - Takei, Yuichi
AU - Hotta, Shogo
AU - Hirano, Jinichi
AU - Tabuchi, Hajime
AU - Mimura, Masaru
N1 - Funding Information:
This work was partially supported by Pfizer (to M.M.) and JSPS KAKENHI (grant number JP 16K10224 to B.Y.). The funder of this study had no role in the study design, data collection and analysis, publication decision, or manuscript preparation. The authors are grateful to Mr. Shingo Kawasaki at Hitachi Co. for technical support. None. This study was approved by the Institutional Review Board at the Keio University School of Medicine. Written informed consent was obtained from all participants prior to the study.
Funding Information:
This work was partially supported by Pfizer (to M.M.) and JSPS KAKENHI (grant number JP 16K10224 to B.Y.). The funder of this study had no role in the study design, data collection and analysis, publication decision, or manuscript preparation.
Publisher Copyright:
© 2019
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Background: Major depressive disorder (MDD) is a heterogeneous condition. Identifying the brain responses to antidepressant treatment is of particular interest as these may represent potential neural networks related to treatment response, forming one aspect of the biological markers of MDD. Near-infrared spectroscopy (NIRS) is suitable for repeated measurements with short intervals because of its noninvasiveness, and can provide detailed time courses of functional alterations in prefrontal regions. Methods: We conducted a 12-week longitudinal study to explore prefrontal hemodynamic changes at 4-week intervals following sertraline treatment in 11 medication-naïve participants with MDD using 52-channel NIRS. Results: While all participants achieved remission after treatment, intra-class correlation coefficient of oxygenated hemoglobin [oxy-Hb] values throughout the 12-week observation was moderate at the spatially and temporally contiguous cluster located in the left inferior frontal and temporal gyri. There was a significant negative correlation between mean [oxy-Hb] values in the significant cluster at 4 weeks and changes in Hamilton Rating Scale for Depression total score from 4 to 8 weeks (r = −0.73, P = 0.011) and from 4 to 12 weeks (r = −0.63, P = 0.039). Limitations: Without healthy controls for comparison, we were unable to fully evaluate whether improvement of [oxy-Hb] activations after treatment in MDD reached normal levels or not. Conclusion: Our NIRS findings of detailed prefrontal hemodynamic alterations over short interval observations such as 4 weeks may have revealed potential trait marker for MDD and biological maker for predicting clinical response to sertraline treatment in MDD.
AB - Background: Major depressive disorder (MDD) is a heterogeneous condition. Identifying the brain responses to antidepressant treatment is of particular interest as these may represent potential neural networks related to treatment response, forming one aspect of the biological markers of MDD. Near-infrared spectroscopy (NIRS) is suitable for repeated measurements with short intervals because of its noninvasiveness, and can provide detailed time courses of functional alterations in prefrontal regions. Methods: We conducted a 12-week longitudinal study to explore prefrontal hemodynamic changes at 4-week intervals following sertraline treatment in 11 medication-naïve participants with MDD using 52-channel NIRS. Results: While all participants achieved remission after treatment, intra-class correlation coefficient of oxygenated hemoglobin [oxy-Hb] values throughout the 12-week observation was moderate at the spatially and temporally contiguous cluster located in the left inferior frontal and temporal gyri. There was a significant negative correlation between mean [oxy-Hb] values in the significant cluster at 4 weeks and changes in Hamilton Rating Scale for Depression total score from 4 to 8 weeks (r = −0.73, P = 0.011) and from 4 to 12 weeks (r = −0.63, P = 0.039). Limitations: Without healthy controls for comparison, we were unable to fully evaluate whether improvement of [oxy-Hb] activations after treatment in MDD reached normal levels or not. Conclusion: Our NIRS findings of detailed prefrontal hemodynamic alterations over short interval observations such as 4 weeks may have revealed potential trait marker for MDD and biological maker for predicting clinical response to sertraline treatment in MDD.
KW - Antidepressant treatment
KW - Depression
KW - Longitudinal study
KW - Near-infrared spectroscopy
KW - Neuroimaging
KW - Sertraline
UR - http://www.scopus.com/inward/record.url?scp=85063900801&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063900801&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2019.04.001
DO - 10.1016/j.jad.2019.04.001
M3 - Article
C2 - 30959413
AN - SCOPUS:85063900801
SN - 0165-0327
VL - 252
SP - 25
EP - 31
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -